Pelvic lymphadenectomy during radical cystectomy: A review of the literature

Rodolfo Hurle, Richard Naspro

Research output: Contribution to journalArticle

Abstract

Currently, radical cystectomy associated with pelvic lymph node dissection is the gold standard surgical treatment for muscle invasive bladder cancer. However, although there is consensus on the need for pelvic lymph node dissection, controversies still exist regarding its extent and exact role. Evidence from the literature is based on retrospective data from high volume, often multicentre studies. Different series report very different templates of lymphadenectomy, thereby complicating data analysis. Furthermore, morbidity related to lymphadenectomy does not seem to be influenced by the extent of the procedure. The role of the pathologist and the modality of node retrieval have a pivotal role in the quality of node assessment. Different prognostic factors regarding node status (number of nodes retrieved, lymphovascular invasion, lymph node density, extracapsular extension, gross node involvement, and extent of primary bladder tumour related to positive nodes) have been introduced and analysed, although the impact on staging and survival are still under investigation. The correct use and assessment of these prognostic factors should help to provide an accurate staging in order to identify those patients who need adjuvant therapy. Future studies should, therefore, be prospective and include all information achievable from a lymphadenectomy.

Original languageEnglish
Pages (from-to)208-220
Number of pages13
JournalSurgical Oncology
Volume19
Issue number4
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Cystectomy
Lymph Node Excision
Urinary Bladder Neoplasms
Multicenter Studies
Lymph Nodes
Morbidity
Muscles
Survival
Therapeutics

Keywords

  • Bladder cancer
  • Cystectomy
  • Extracapsular extension prognosis
  • Lymph node density
  • Lymph node dissection
  • Lymph node metastasis
  • Lymphadenectomy
  • Lymphovascular invasion
  • Transitional cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Pelvic lymphadenectomy during radical cystectomy : A review of the literature. / Hurle, Rodolfo; Naspro, Richard.

In: Surgical Oncology, Vol. 19, No. 4, 12.2010, p. 208-220.

Research output: Contribution to journalArticle

@article{2dd166a5325043d5aae2a20d13ab4260,
title = "Pelvic lymphadenectomy during radical cystectomy: A review of the literature",
abstract = "Currently, radical cystectomy associated with pelvic lymph node dissection is the gold standard surgical treatment for muscle invasive bladder cancer. However, although there is consensus on the need for pelvic lymph node dissection, controversies still exist regarding its extent and exact role. Evidence from the literature is based on retrospective data from high volume, often multicentre studies. Different series report very different templates of lymphadenectomy, thereby complicating data analysis. Furthermore, morbidity related to lymphadenectomy does not seem to be influenced by the extent of the procedure. The role of the pathologist and the modality of node retrieval have a pivotal role in the quality of node assessment. Different prognostic factors regarding node status (number of nodes retrieved, lymphovascular invasion, lymph node density, extracapsular extension, gross node involvement, and extent of primary bladder tumour related to positive nodes) have been introduced and analysed, although the impact on staging and survival are still under investigation. The correct use and assessment of these prognostic factors should help to provide an accurate staging in order to identify those patients who need adjuvant therapy. Future studies should, therefore, be prospective and include all information achievable from a lymphadenectomy.",
keywords = "Bladder cancer, Cystectomy, Extracapsular extension prognosis, Lymph node density, Lymph node dissection, Lymph node metastasis, Lymphadenectomy, Lymphovascular invasion, Transitional cell carcinoma",
author = "Rodolfo Hurle and Richard Naspro",
year = "2010",
month = "12",
doi = "10.1016/j.suronc.2009.05.004",
language = "English",
volume = "19",
pages = "208--220",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Pelvic lymphadenectomy during radical cystectomy

T2 - A review of the literature

AU - Hurle, Rodolfo

AU - Naspro, Richard

PY - 2010/12

Y1 - 2010/12

N2 - Currently, radical cystectomy associated with pelvic lymph node dissection is the gold standard surgical treatment for muscle invasive bladder cancer. However, although there is consensus on the need for pelvic lymph node dissection, controversies still exist regarding its extent and exact role. Evidence from the literature is based on retrospective data from high volume, often multicentre studies. Different series report very different templates of lymphadenectomy, thereby complicating data analysis. Furthermore, morbidity related to lymphadenectomy does not seem to be influenced by the extent of the procedure. The role of the pathologist and the modality of node retrieval have a pivotal role in the quality of node assessment. Different prognostic factors regarding node status (number of nodes retrieved, lymphovascular invasion, lymph node density, extracapsular extension, gross node involvement, and extent of primary bladder tumour related to positive nodes) have been introduced and analysed, although the impact on staging and survival are still under investigation. The correct use and assessment of these prognostic factors should help to provide an accurate staging in order to identify those patients who need adjuvant therapy. Future studies should, therefore, be prospective and include all information achievable from a lymphadenectomy.

AB - Currently, radical cystectomy associated with pelvic lymph node dissection is the gold standard surgical treatment for muscle invasive bladder cancer. However, although there is consensus on the need for pelvic lymph node dissection, controversies still exist regarding its extent and exact role. Evidence from the literature is based on retrospective data from high volume, often multicentre studies. Different series report very different templates of lymphadenectomy, thereby complicating data analysis. Furthermore, morbidity related to lymphadenectomy does not seem to be influenced by the extent of the procedure. The role of the pathologist and the modality of node retrieval have a pivotal role in the quality of node assessment. Different prognostic factors regarding node status (number of nodes retrieved, lymphovascular invasion, lymph node density, extracapsular extension, gross node involvement, and extent of primary bladder tumour related to positive nodes) have been introduced and analysed, although the impact on staging and survival are still under investigation. The correct use and assessment of these prognostic factors should help to provide an accurate staging in order to identify those patients who need adjuvant therapy. Future studies should, therefore, be prospective and include all information achievable from a lymphadenectomy.

KW - Bladder cancer

KW - Cystectomy

KW - Extracapsular extension prognosis

KW - Lymph node density

KW - Lymph node dissection

KW - Lymph node metastasis

KW - Lymphadenectomy

KW - Lymphovascular invasion

KW - Transitional cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77957804314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957804314&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2009.05.004

DO - 10.1016/j.suronc.2009.05.004

M3 - Article

C2 - 19500973

AN - SCOPUS:77957804314

VL - 19

SP - 208

EP - 220

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 4

ER -